usos y posibilidades terapéuticas de la procaína endovenosa

Clicks: 124
ID: 151968
1950
Article Quality & Performance Metrics
Overall Quality
Not rated
Combines reader engagement with the AI quality analysis. This article has not been analysed, so there is no overall score — reader engagement is measured and shown alongside.
AI Quality Assessment
Not analyzed
Readership in this journal
Steady

Ranked #105 of 320 articles by views in european journal of cancer prevention : the official journal of the european cancer prevention organisation (ecp)

Most read Least read

Bar heights use a square-root scale. Only the 120 most-read articles are drawn; the journal has 320 in total.

Mint this article as an NFT
Not yet minted

Create a permanent, verifiable on-chain record of this article on the Scimatic Network. The NFT is held in your Journament account, and you can withdraw it to your own wallet at any time.

5 SUSD one-off · no wallet required
Abstract
No es explicable que hasta hace pocos años, se le tuviera a la inyección incidental de anestésicos sintéticos tanto temor como a la aplicación de un aceite, una grasa o una embolia masiva de aire en las venas, ya que si recordamos un poco la historia de la medicina en general, vemos como Sir Christopher Wren, el creador de la inyección endovenosa, trabajo experimentalmente en la aplicación de soluciones sin titular de Cocaína en las venas de un perro.
Reference Key
restrepo1950revistausos Use this key to autocite in the manuscript while using SciMatic Manuscript Manager or Thesis Manager
Authors ;Max Olaya Restrepo
Journal european journal of cancer prevention : the official journal of the european cancer prevention organisation (ecp)
Year 1950
DOI
DOI not found
URL
Keywords

Citations

No citations found. To add a citation, contact the admin at info@scimatic.org

No comments yet. Be the first to comment on this article.